GSK, Sanofi begin new Covid-19 vaccine trial after setback last year
February 22, 2021 at 06:21 AM EST
Britain's GlaxoSmithKline and France's Sanofi on Monday said they had started a new clinical trial of their protein-based Covid-19 vaccine candidate.
